We use essential cookies to make our site work. With your consent, we may also use analytics cookies. Cookie Policy
Cyprus AI builder · IP and pre-IPO review
Map ownership of code, training assets and licences; calculate the modified-nexus fraction; keep IP Box and additional R&D deductions separate; and confirm listing eligibility with the chosen exchange and advisers.
Request a free 30-minute initial consultation.
— WHAT YOU GET
Cyprus IP Box (Article 9(1)(k) ITL) covers COPYRIGHTED SOFTWARE — including ML model code, training pipeline, inference engine, surrounding SaaS application. Pre-trained foundation models licensed in: not your IP. Your fine-tuned derivative + supporting code + ML-pipeline: qualifies.
The additional 20% R&D deduction covers qualifying expenditure incurred in 2025–2030. It excludes expenditure on an eligible intangible asset for which IP Box has applied in any year, including the current year (Article 9(1)(d)).
12-24 month IPO-readiness arc: Cyprus IP HoldCo + Cyprus operational substance + IFRS-compliant audit + governance upgrade + IFR / IFD-equivalent compliance + share-class rationalisation. NASDAQ Form F-1 acceptable. LSE Main Market / AIM acceptable. Euronext acceptable.
OECD Nexus Fraction rewards Cyprus-resident R&D. ML engineers Cyprus-resident: nexus near 1.0 (full IP Box benefit). Hybrid teams (some Cyprus, some remote): nexus reduces proportionally. Target ≥70% Cyprus-resident ML engineering headcount for optimal nexus.
— EVERYTHING INCLUDED
— PROCESS
Identify qualifying IP (ML model code, training pipeline, surrounding SaaS). Quantify R&D footprint vs Cyprus-resident vs other-jurisdiction. Model effective Cyprus IP Box rate + projected R&D super-deduction.
Cyprus Ltd Business tier (10 working days). Cyprus office + first Cyprus-resident ML engineer. Initial board meeting authorising IP acquisition.
Legal opinion on qualifying-IP characterisation. Nexus methodology. Expense-attribution model. ATR (€4,000-€5,500 + VAT pro fee + €1,000/€2,000 gov fee) for binding pre-clearance — recommended for €10M+ ARR.
12-24 month arc: IFRS-compliant audit, governance + committees, internal controls, share-class consolidation, prospectus drafting. Cyprus parent listing-jurisdiction-compatible.
The engagement can document the Cyprus structure, assumptions and evidence for review by the company’s investors, transaction advisers and relevant authorities. Acceptance cannot be guaranteed.
— COMMON QUESTIONS
Yes — copyrighted ML model code (model architecture, training pipeline, inference engine, deployment infrastructure, surrounding SaaS) qualifies as copyrighted software under Cyprus IP Box. Pre-trained foundation models you license in: separate licensing arrangement; your fine-tuned derivative + supporting code: qualifies.
EU AI Act applies uniformly across all EU member states including Cyprus. Cyprus offers no carve-outs from the Act but doesn't impose stricter local requirements. AI Act compliance + Cyprus tax structuring are complementary; coordinate with EU regulatory counsel.
Yes — via foreign-private-issuer (FPI) route. Cyprus parent files Form F-1 (not Form S-1). EU-parent NASDAQ listings exist. Cyprus accepted alongside Ireland / Netherlands / Luxembourg for AI-startup parents.
Common pattern for US-VC-backed AI startups: Delaware C-corp topco + Cyprus IP HoldCo. Delaware satisfies US-VC familiarity; Cyprus delivers IP Box + EU access. Each side: separate tax-residency, hybrid-entity classification, US §367 + GILTI considerations.
Yes — cloud compute spend (AWS / GCP / Azure / specialised ML providers) is fully deductible business expense. Where attributed to qualifying R&D activity, also qualifies for the 20% R&D super-deduction.
Dataset purchase / licensing: deductible as research expense (or capitalised + depreciated for long-life datasets). Qualifying R&D dataset acquisition: included in super-deduction base. Customer-data: separate considerations (GDPR + monetisation rules).
Send your enquiry for a no-obligation initial review.